Literature DB >> 8404588

Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells: the role of sialylation and sulfation in TSH bioactivity.

M W Szkudlinski1, N R Thotakura, I Bucci, L R Joshi, A Tsai, J East-Palmer, J Shiloach, B D Weintraub.   

Abstract

The biological significance of glycosylation variants of pituitary glycoprotein hormones remains controversial because of the indirect methods usually employed to determine carbohydrate composition or structure as well as the use of unreliable biological/immunological ratio to determine bioactivity. We have previously characterized recombinant human TSH (rhTSH) secreted by Chinese hamster ovary cells attached to microcarrier beads in a large scale bioreactor after stable transfection of hCG alpha and hTSH beta minigenes. In the present study rhTSH has been used as a model to determine structure-function relationships of different isoforms of glycoprotein hormones. We have now produced greater than 200 mg rhTSH using a hollow fiber bioreactor. The highly purified rhTSH produced in the hollow fiber bioreactor (rhTSH-N) as well as rhTSH commercially produced in a large scale bioreactor (rhTSH-G) were quantitated by immunoassays, receptor binding assay, and amino acid analysis and further characterized by a variety of physico-biochemical methods, including chromatofocusing and carbohydrate analysis. rhTSH-G, rhTSH-N, as well as pituitary human TSH (phTSH) have been separated by chromatofocusing on a Mono P column into several isoforms with different pI values. Compositional analysis of the fractions showed higher sialic acid content in the more acidic rhTSH-G fractions. phTSH acidic isoforms showed higher total sulfate and sialic acid contents than the more basic fractions. The bioactivities of various TSH isoforms based on rigorous quantitation of mass by amino acid analysis determined in three different FRTL-5 cell bioassays showed that the more basic and less sialylated fractions of rhTSH-G were more active than the more acidic fractions. In contrast to the in vitro data, highly sialylated and acidic rhTSH-G isoforms showed longer plasma half-lives and higher in vivo bioactivity than the basic forms. These results indicate that secreted rhTSH, similar to intrapituitary phTSH, exists as a mixture of charge isoforms that are related at least in part to the degree of sialylation. The degree of sialylation, highly dependent on the bioreactor production conditions, appears to be the major factor affecting the charge heterogeneity, MCR, and bioactivity of rhTSH.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8404588     DOI: 10.1210/endo.133.4.8404588

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

Review 1.  The use of recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer.

Authors:  M C Skarulis
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Congenital nephrotic syndrome with dysmorphic features and death in early infancy: Answers.

Authors:  Julien Heinrich Park; Martin Weissensteiner; Oliver Wagner; Yoshinao Wada; Stephan Rust; Janine Reunert; Thorsten Marquardt
Journal:  Pediatr Nephrol       Date:  2015-05-09       Impact factor: 3.714

3.  Label-free quantitation: a new glycoproteomics approach.

Authors:  Kathryn R Rebecchi; Jamie L Wenke; Eden P Go; Heather Desaire
Journal:  J Am Soc Mass Spectrom       Date:  2009-03-09       Impact factor: 3.109

4.  Tissue-specific posttranslational modification allows functional targeting of thyrotropin.

Authors:  Keisuke Ikegami; Xiao-Hui Liao; Yuta Hoshino; Hiroko Ono; Wataru Ota; Yuka Ito; Taeko Nishiwaki-Ohkawa; Chihiro Sato; Ken Kitajima; Masayuki Iigo; Yasufumi Shigeyoshi; Masanobu Yamada; Yoshiharu Murata; Samuel Refetoff; Takashi Yoshimura
Journal:  Cell Rep       Date:  2014-10-30       Impact factor: 9.423

5.  Use of recombinant human thyroid-stimulating hormone for thyrotropin stimulation test in euthyroid dogs.

Authors:  F Sauvé; M Paradis
Journal:  Can Vet J       Date:  2000-03       Impact factor: 1.008

6.  Total Chemical Synthesis of Human Thyroid-Stimulating Hormone (hTSH) β-Subunit: Application of Arginine-tagged Acetamidomethyl (AcmR) Protecting Groups.

Authors:  John A Brailsford; Jennifer L Stockdill; Abram J Axelrod; Michael T Peterson; Paul A Vadola; Eric V Johnston; Samuel J Danishefsky
Journal:  Tetrahedron       Date:  2018-03-06       Impact factor: 2.457

7.  Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium.

Authors:  Daniele Barbaro; Mariano Grosso; Giuseppe Boni; Paola Lapi; Cristina Pasquini; Paola Orsini; Anna Turco; Giuseppe Meucci; Maria Cristina Marzola; Piero Berti; Paolo Miccoli; Giuliano Mariani; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-04       Impact factor: 9.236

8.  Recombinant thyrotropin for detection of recurrent thyroid cancer.

Authors:  Paul W Ladenson
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

9.  Influence of a reduced CO2 environment on the secretion yield, potency and N-glycan structures of recombinant thyrotropin from CHO cells.

Authors:  João Ezequiel Oliveira; Renata Damiani; Karola Vorauer-Uhl; Paolo Bartolini; Maria Teresa C P Ribela
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

10.  Subunit-specific functions of N-linked oligosaccharides in human thyrotropin: role of terminal residues of alpha- and beta-subunit oligosaccharides in metabolic clearance and bioactivity.

Authors:  M W Szkudlinski; N R Thotakura; B D Weintraub
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.